SCHEMBL26337410

SCHEMBL26337410

c1ccc(-c2ccc3cc(N(c4cccc(-c5ccc6c(c5)c(-c5ccccc5)c(-c5ccccc5)c5ccccc56)c4)c4ccc5cc(-c6ccccc6)ccc5c4)ccc3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.40
ESR2 Q92731 6/20 0.40
HSD17B1 P14061 6/20 0.40
HSD17B2 P37059 6/20 0.40
CYP1A2 P05177 3/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C9 P11712 3/20 0.40
CYP2B6 P20813 3/20 0.40
CYP2C19 P33261 3/20 0.40
BACE1 P56817 1/20 0.35
GPR84 Q9NQS5 1/20 0.35
NPC1 O15118 1/20 0.33
CDK4 P11802 2/20 0.32
CCND1 P24385 2/20 0.32
FGFR1 P11362 1/20 0.32
DYRK3 O43781 1/20 0.32
CLK1 P49759 1/20 0.32
CLK2 P49760 1/20 0.32
CLK3 P49761 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26337413 0.97 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26337419 0.97 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26337405 0.96 ESR1 (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26337505 0.96 ESR1 (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26337511 0.96 ESR1 (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26339893 0.96 ESR1 (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26339921 0.96 ESR1 (0.38) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26337456 0.96 HSD17B1 (0.40) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26337509 0.95 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2
SCHEMBL26337571 0.95 ESR1 (0.39) ESR1ESR2HSD17B1HSD17B2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 US disclosed
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301176-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE LEF1, ELAVL1, PIEZO1 ESR1 74/4885ESR2 419/4885HSD17B1 2697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.